SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-024118
Filing Date
2020-04-10
Accepted
2020-04-10 14:05:52
Documents
1
Period of Report
2020-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7390
  Complete submission text file 0001209191-20-024118.txt   9039
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Issuer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 20725 S. WESTERN BLVD. SUITE 136 TORRANCE CA 90501
Business Address
Niihara Yutaka (Reporting) CIK: 0001517691 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35527 | Film No.: 20786588